Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Tempest Therapeutics, Inc. (TPST)

CollPlant Biotechnologies Ltd. Sponsored ADR and Tempest Therapeutics, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Tempest Therapeutics, Inc. are of similar size ($7.5M and $7.5M). Tempest Therapeutics, Inc. grew revenue faster over the last twelve months: −53.0% against −86.8%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Tempest Therapeutics, Inc. leads on 8 and CollPlant Biotechnologies Ltd. Sponsored ADR on 6.

Valuation

Metric CLGN TPST Biotechnology median
P/E n/m n/m 10.60
P/S 17.47 17.86 9.40
P/B 1.89 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 25.34 22.37 9.02
Earnings yield (246.04%) (1,178.26%) (32.88%)
Free cash flow yield (202.39%) (365.85%) (23.13%)

Profitability

Metric CLGN TPST Biotechnology median
Gross margin (321.70%) 0.00% 68.51%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (931.14%) (51.96%)
Return on assets (101.59%) (237.25%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN TPST Biotechnology median
Revenue growth (TTM) (86.76%) (52.98%) 6.76%
EPS growth (last fiscal year) 35.17% 67.55% 29.88%
Revenue growth, 5-year CAGR (17.32%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 0.38 4.97
Net debt to EBITDA 0.56 0.29 1.01

Dividend

Metric CLGN TPST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN TPST Biotechnology median
Market cap 7.45m 7.50m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack